site stats

Crispr stock 5 year forecast

WebApr 12, 2024 · To see how CRISPR Therapeutics AG stock has been performing today in comparison to its peers in the industry, here are the numbers: CRSP stock’s performance was -1.40% at last check in today’s session, and -27.34% in the past year, while Pieris Pharmaceuticals Inc. (PIRS) has been trading -0.88% in recent session and positioned … Web1 day ago · The CRISPR technology market size is forecasted to increase by USD 2.88 billion from 2024 to 2026, at a CAGR of 19.34%, according to a recent market study by Technavio. The growth of the market ...

CRISPR Therapeutics (CRSP) stock forecast for 2026

WebJul 17, 2024 · Five years from now, CRISPR Therapeutics ( CRSP 1.34%) may well be a household name as a result of awe-inspiring early results … WebApr 6, 2024 · What are analysts forecasts for CRISPR Therapeutics stock? The 50 analysts offering price forecasts for CRISPR Therapeutics have a median target of 97.44, with a high estimate of 172.00 and a low ... jem star https://e-shikibu.com

CRISPR Therapeutics - CRSP Stock Forecast, Price & News - MarketBeat

WebStock Price Forecast. The 26 analysts offering 12-month price forecasts for CRISPR Therapeutics AG have a median target of 72.50, with a high estimate of 220.00 and a … Web4 hours ago · This company is expected to post quarterly loss of $1.67 per share in its upcoming report, which represents a year-over-year change of +28%. Revenues are expected to be $37.61 million, up 3901.5% ... WebCRSP Stock 12 Months Forecast. Based on 17 Wall Street analysts offering 12 month price targets for Crispr Therapeutics AG in the last 3 months. The average price target is $77.69 with a high forecast of $143.00 and a low forecast of $39.00. The average price target represents a 71.12% change from the last price of $45.40. jem stack game

Business and Financial News - CNN Money

Category:CRISPR and CRISPR-Associated (Cas) Genes Market 2024-2030

Tags:Crispr stock 5 year forecast

Crispr stock 5 year forecast

Crispr Therapeutics AG (CRSP) Stock Forecast & Price Target

WebApr 14, 2024 · Report Coverage. Details. Base Year: 2024 . Market Size in 2024: US$ 604.7 Mn. Historical Data for: 2024 to 2024. Forecast Period: 2024 to 2030. Forecast Period 2024 to 2030 CAGR:

Crispr stock 5 year forecast

Did you know?

WebApr 10, 2024 · See the latest CRISPR Therapeutics AG stock price (NASDAQ:CRSP), related news, valuation, dividends and more to help you make your investing decisions. ... Year Range 38.94 – 86.95. WebNext reporting date: May 8, 2024: EPS forecast (this quarter)-$0.48: Annual revenue (last year) $13.9M: Annual profit (last year)-$99.4M: Net profit margin

WebApr 11, 2024 · Get a real-time CRISPR Therapeutics AG (CRSP) stock price quote with breaking news, financials, statistics, charts and more. ... 5Y 5 Years; Max; 0.71% (1D) … WebSee CRISPR Therapeutics AG (CRSP) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.

WebApr 12, 2024 · To see how CRISPR Therapeutics AG stock has been performing today in comparison to its peers in the industry, here are the numbers: CRSP stock’s … WebCRSP Stock 12 Months Forecast. Based on 17 Wall Street analysts offering 12 month price targets for Crispr Therapeutics AG in the last 3 months. The average price target is …

WebOct 15, 2024 · About the CRISPR Therapeutics AG stock forecast. As of 2024 April 11, Tuesday current price of CRSP stock is 45.090$ and our data indicates that the asset …

WebApr 13, 2024 · The firm’s revenue for the quarter was down 53.5% compared to the same quarter last year. Research analysts forecast that CRISPR Therapeutics will post -7.35 EPS for the current year. ... Insiders sold a total of 75,000 shares of company stock worth $3,604,500 over the last three months. 5.30% of the stock is currently owned by … jem starbrightWebJan 18, 2024 · Yahoo Finance. The above is based on 19 Wall Street analysts offering 12-month price targets for CRISPR Therapeutics in the last 3 months. The average price target is $149.11 with a high forecast ... jems take a plate menu portsmouth vaWeb4 hours ago · This company is expected to post quarterly loss of $1.67 per share in its upcoming report, which represents a year-over-year change of +28%. Revenues are … jemstock 2WebApr 9, 2024 · CRISPR previously forecast that exa-cel has a "multibillion-dollar opportunity," but that could take years to realize. Plus the company will split profits with Vertex -- it will take 60%, leaving ... jem startWebApr 4, 2024 · The CRISPR Therapeutics stock prediction results are shown below and presented as a graph, table and text information. CRISPR Therapeutics stock forecasts … jem steamboatWebCRISPR Therapeutics Stock Forecast and Price Target. ... In the last year, CRISPR Therapeutics's Price has decreased by 100.00%, going from $17.55 to $0.00. In the next … jem star cateringWebApr 13, 2024 · The firm's revenue for the quarter was down 53.5% compared to the same quarter last year. Research analysts forecast that CRISPR Therapeutics will post -7.35 EPS for the current year. Insiders Place Their Bets. In other CRISPR Therapeutics news, CEO Samarth Kulkarni sold 25,000 shares of the stock in a transaction that occurred on … jem stars